BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30068692)

  • 1. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
    Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
    Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH; Field HP; Yasmin E; Balen AH
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements.
    Yang Y; Ding M; Di N; Azziz R; Yang D; Zhao X
    J Clin Lab Anal; 2019 Mar; 33(3):e22699. PubMed ID: 30350882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
    Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
    PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
    Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
    Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
    Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
    Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
    Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
    Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The free androgen index is inaccurate in women when the SHBG concentration is low.
    Keevil BG; Adaway J; Fiers T; Moghetti P; Kaufman JM
    Clin Endocrinol (Oxf); 2018 May; 88(5):706-710. PubMed ID: 29405348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
    Cheng V; Doshi KB; Falcone T; Faiman C
    Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary testosterone may not serve as a screening test in the diagnosis of biochemical hyperandrogenism.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Kondracka A; Gajda S; Sieńko D
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1118-1125. PubMed ID: 29517119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratio of ovarian stroma and total ovarian area by ultrasound in prediction of hyperandrogenemia in reproductive-aged Thai women with polycystic ovary syndrome: a diagnostic test.
    Leerasiri P; Wongwananuruk T; Rattanachaiyanont M; Indhavivadhana S; Techatraisak K; Angsuwathana S
    J Obstet Gynaecol Res; 2015 Feb; 41(2):248-53. PubMed ID: 25227757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort.
    Glintborg D; Jensen RC; Bentsen K; Schmedes AV; Brandslund I; Kyhl HB; Bilenberg N; Andersen MS
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3819-3827. PubMed ID: 30060213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry.
    Haring R; Hannemann A; John U; Radke D; Nauck M; Wallaschofski H; Owen L; Adaway J; Keevil BG; Brabant G
    J Clin Endocrinol Metab; 2012 Feb; 97(2):408-15. PubMed ID: 22162468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.